$康希诺生物—B(0_老虎社区_美港股上老虎

CindyY
2019-03-28

$康希诺生物—B(06185)$

产品线丰富，15个疫苗涵盖12种疾病，目前亏损阶段，但在研药物中已有进入新药申请，MCV-2脑膜炎球菌结合疫苗在今年一月已经提交新药申请，计划年底上市，MCV-4也预计今年提交新药申请

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":446712,"tweetId":"446712","gmtCreate":1553734129220,"gmtModify":1704795331507,"author":{"id":3435310542032743,"idStr":"3435310542032743","authorId":3435310542032743,"authorIdStr":"3435310542032743","name":"CindyY","avatar":"https://static.tigerbbs.com/4d448dda69a831bbf10db05c4dc47653","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":40,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body>$康希诺生物—B(06185)$ 产品线丰富，15个疫苗涵盖12种疾病，目前亏损阶段，但在研药物中已有进入新药申请，MCV-2脑膜炎球菌结合疫苗在今年一月已经提交新药申请，计划年底上市，MCV-4也预计今年提交新药申请 </body></html>","htmlText":"<html><head></head><body>$康希诺生物—B(06185)$ 产品线丰富，15个疫苗涵盖12种疾病，目前亏损阶段，但在研药物中已有进入新药申请，MCV-2脑膜炎球菌结合疫苗在今年一月已经提交新药申请，计划年底上市，MCV-4也预计今年提交新药申请 </body></html>","text":"$康希诺生物—B(06185)$ 产品线丰富，15个疫苗涵盖12种疾病，目前亏损阶段，但在研药物中已有进入新药申请，MCV-2脑膜炎球菌结合疫苗在今年一月已经提交新药申请，计划年底上市，MCV-4也预计今年提交新药申请","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/446712","repostId":0,"isVote":1,"tweetType":1,"viewCount":3112,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["06185"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":185,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}